HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy?
HIV-PIs (HIV protease inhibitors) have proved to be of great benefit for the millions of people suffering from AIDS. However, one of the side effects of this component of combined highly active antiretroviral therapy is lipodystrophy, which affects a large number of the patients taking this class of...
المؤلفون الرئيسيون: | Goulbourne, C, Vaux, D |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
Portland Press
2010
|
مواد مشابهة
-
The structural basis of ZMPSTE24-dependent laminopathies
حسب: Quigley, A, وآخرون
منشور في: (2013) -
The structural basis of ZMPSTE24-dependent laminopathies.
حسب: Quigley, A, وآخرون
منشور في: (2013) -
Prelamin A and ZMPSTE24 in premature and physiological aging
حسب: Howard J. Worman, وآخرون
منشور في: (2023-12-01) -
ZMPSTE24 Is Associated with Elevated Inflammation and Progerin mRNA
حسب: Moritz Messner, وآخرون
منشور في: (2020-08-01) -
Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24.
حسب: Jemima Barrowman, وآخرون
منشور في: (2012-01-01)